---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-391952"
form_type: "8-K"
ticker: "PBLS"
cik: "0001657677"
company_name: "Parabilis Medicines, Inc."
filed_at: "2026-09-15T20:15:35+00:00"
generated_at: "2026-09-15T20:17:12.627883+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "medium"
source: SEC EDGAR
---

# Parabilis to present updated zolucatetide data in desmoid tumors at ESMO 2026

## Summary
- Updated Phase 1/2 zolucatetide data in desmoid tumors to be presented at ESMO Congress 2026 in Madrid.
- Oral presentation scheduled Oct 24, 2:45pm CEST in sarcoma-focused Proffered Paper session.
- Company updates guidance to reflect intention to present data; no numbers disclosed yet.

## SEC filing metadata
- accession: 0001193125-26-391952
- form_type: 8-K
- ticker: PBLS
- cik: 0001657677
- company_name: Parabilis Medicines, Inc.
- filed_at: 2026-09-15T20:15:35+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: medium
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1657677/000119312526391952/0001193125-26-391952-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1657677/000119312526391952/ck0001657677-20260915.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-391952
- JSON: https://secwatch.observer/filing/0001193125-26-391952.json
- Plain text: https://secwatch.observer/filing/0001193125-26-391952.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.